|
Volumn 177, Issue 12, 2007, Pages 1524-1525
|
Vaccination against human papillomavirus [2]
a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
WART VIRUS VACCINE;
CANCER MORTALITY;
CANCER PREVENTION;
CANCER SCREENING;
CHILDHOOD CANCER;
DISEASE COURSE;
GOVERNMENT;
HEALTH CARE POLICY;
HUMAN;
IMMUNE RESPONSE;
INCIDENCE;
LETTER;
ONCOGENE;
PAPANICOLAOU TEST;
PELVIS EXENTERATION;
SAFE SEX;
UTERINE CERVIX CANCER;
VACCINATION;
WART VIRUS;
CANADA;
FEMALE;
MALE;
NOTE;
PREVALENCE;
TREATMENT OUTCOME;
UTERINE CERVIX TUMOR;
VIRUS INFECTION;
ADOLESCENT;
ADULT;
COST BENEFIT ANALYSIS;
ECONOMICS;
EVIDENCE BASED MEDICINE;
METHODOLOGY;
CANADA;
FEMALE;
HUMANS;
INCIDENCE;
MALE;
PAPILLOMAVIRUS INFECTIONS;
PAPILLOMAVIRUS VACCINES;
PREVALENCE;
TREATMENT OUTCOME;
UTERINE CERVICAL NEOPLASMS;
ADOLESCENT;
ADULT;
COST-BENEFIT ANALYSIS;
EVIDENCE-BASED MEDICINE;
|
EID: 37049009296
PISSN: 08203946
EISSN: 14882329
Source Type: Journal
DOI: 10.1503/cmaj.1070120 Document Type: Letter |
Times cited : (4)
|
References (4)
|